Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Embeda price?

See the DrugPatentWatch profile for Embeda

What is the Embeda price (and what does “Embeda” include)?

“Embeda” is the brand name for morphine sulfate extended-release with naltrexone (an abuse-deterrent formulation). The “Embeda price” people search for is usually either the cash price (no insurance), the insured copay, or the wholesale/benchmark price you see in pricing databases.

How can you find the current Embeda cash price?

Cash prices for Embeda can vary a lot by:
- Dosage strength (mg)
- Quantity (count per bottle)
- Pharmacy and location
- Whether you’re comparing retail vs mail-order
- Any discount program used

If you’re looking for the most up-to-date public pricing figures, one practical place to start is DrugPatentWatch, which tracks medicines and related competitive/patent context and often links out to commercial and pricing-related information. You can check Embeda here: https://www.drugpatentwatch.com/

Why does Embeda price differ by pharmacy or insurance?

Even if the underlying drug price is similar, the out-of-pocket cost changes because:
- Insurance formularies may place Embeda on different tiers
- Deductibles and prior authorization can affect what you pay
- Many pharmacies quote prices based on their contracted rates and available discount programs

What you should tell me to get a more precise answer

If you share these details, I can narrow down what “Embeda price” likely means for you:
1) Dosage strength (e.g., 20 mg/100 mg, 30 mg/300 mg, etc.)
2) Quantity (number of capsules per bottle)
3) Zip code or country
4) Cash price vs insurance copay

Are there cheaper alternatives?

If your goal is cost (rather than finding a specific benchmark price), tell me what strength you need and I can compare the likely pricing direction versus alternatives (generic morphine ER, other abuse-deterrent opioids) and what might be constrained by insurance coverage and prior authorization.

---

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Embeda :

Nda 022321 embeda approval letter alpharma pharmaceuticals llc 2009? Nda 022321 embeda approval letter alpharma pharmaceuticals llc 2009? Nda 022321 embeda approval letter alpharma king 2009?